Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs T2D.com

AM Rx
Graded #491

Lower grade

vs+3.3999999999999986
T2D.com
Graded #475

Higher grade

The verdict

T2D.com takes it — 53/100 to 49.6/100.

T2D.com grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. T2D.com offers a complete service for compounded semaglutide and tirzepatide that includes the prescriber, medication, and home delivery in one integrated solution.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAM Rx +21
50
29
Dose & formulationAM Rx +1
65
64
Clinical oversightT2D.com +28
41
69
Labs & monitoringT2D.com +3
49
52
FulfillmentEven
58
58
Contract termsT2D.com +35
20
55
AM Rx · left barT2D.com · right bar

The numbers

MetricAM RxT2D.com
WeighScore49.6/10053/100
GradeCC
Scorecard rank#491#475
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)$999/mo (starting dose, compounded)
TirzepatideNot disclosed$999/mo (starting dose, compounded)
CoverageCoverage not published1 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
AM Rx

Graded #491 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
T2D.com

Graded #475 · C

Strengths

  • Built specifically for type 2 diabetic and pre-diabetic patients
  • Integrated service — prescriber, pharmacy, and delivery handled in one flow
  • Offers both compounded semaglutide and compounded tirzepatide
  • Temperature-controlled home delivery via UPS or FedEx
  • Ongoing prescriber monitoring and support included

Where it loses points

  • No pricing published on the public website — must register to see costs
  • No states list published on the site
  • Newer brand with limited independent reviews
  • Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard